Consumer Goods
J&J Slumps on Soft Outlook
Stock quotes in this article:JNJ
Updated from 3:12 p.m. EST
Johnson & Johnson's (JNJ) shares closed to the downside Tuesday amid a weak forecast from the company and a down day overall for the U.S. stock market. The New Jersey-based drug and consumer-products giant predicted earnings for 2009 of $4.45 to $4.55 a share, which excludes the impact of certain items, but includes a reduction of 3 cents to 5 cents from the pending acquisition of Mentor (MNT). On average, analysts surveyed by Thomson Reuters are calling for $4.61. J&J's outlook came as the company reported fourth-quarter earnings of $2.7 billion, or 97 cents a share. Before items, the company would have earned 94 cents, 2 cents better than expectations. In the same quarter last year, J&J had a profit of $2.4 billion, or 82 cents a share. Worldwide sales in the quarter fell 4.9% year over year to $15.2 billion, a decline that was primarily attributable to unfavorable exchange rates, and missed Wall Street's $15.9 billion consensus estimate. Sales rose 4.3% for the full year to $63.7 billion, and adjusted earnings were $4.55 a share. Shares of J&J closed down 69 cents, or 1.2%, to $56.75, after at one point being one of only four stocks in the Dow Jones Industrial Average that was up for the day, along with Merck (MRK), AT&T (T) and Verizon (VZ). J&J peers Pfizer (PFE) and Procter & Gamble (PG) were slightly lower.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |


Connect with TheStreet